Nyha
Rediff.com » News » Nyha
Videos for Nyha
Web results for Nyha
Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
DEERFIELD, Ill. and OSAKA, Japan, June 17, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary,... ...
http://www.dnaindia.com/pressreleases/1849453/press-release-takeda-type-2-diabetes-therapies-nesina-alogliptin-and-fixed-dose-combinations-kazano-alogliptin-and-metformin-hcl-and-oseni-alogliptin-and-pioglitazone-are-now-available-in-pharmacies-in-the-uniTwo Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes..
Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients ... Abbott labs... ...
http://in.advfn.com/p.php?pid=nmona&article=57850259First drug to improve heart failure mortality in over a decade
: Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at... ...
http://www.rxpgnews.com/research/First-drug-to-improve-heart-failure-mortality-in-over-a-decade_638042.shtmlPar Pharmaceutical Begins Shipment of Generic Atacand®
PR Newswire WOODCLIFF LAKE, N.J., May 22, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has entered into an... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=46048&title=Par-Pharmaceutical-Begins-Shipment-of-Generic-Atacand®Zensun Announces Positive Clinical Results for Neucardin to Improve Heart Function and Reduce Mortality in Chronic Heart Failure Patients
/PRNewswire/ -- Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four... ...
http://www.dnaindia.com/pressreleases/1838597/press-release-zensun-announces-positive-clinical-results-for-neucardin-to-improve-heart-function-and-reduce-mortality-in-chronic-heart-failure-patientsTop Coverage News
© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly